{"id":620503,"date":"2025-12-08T17:39:13","date_gmt":"2025-12-08T17:39:13","guid":{"rendered":"https:\/\/www.europesays.com\/uk\/620503\/"},"modified":"2025-12-08T17:39:13","modified_gmt":"2025-12-08T17:39:13","slug":"blood-pressure-medication-recalled-for-potential-cross-contamination-reports-say","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/uk\/620503\/","title":{"rendered":"Blood pressure medication recalled for potential cross-contamination, reports say"},"content":{"rendered":"<p class=\"text | article-text\">(Gray News) &#8211; Blood pressure medicine has been recalled because it may be cross-contaminated with another medication, according to reports.<\/p>\n<p class=\"text | article-text\"><a href=\"https:\/\/www.usatoday.com\/story\/news\/health\/2025\/12\/06\/blood-pressure-drug-recall-ziac-cross-contamination\/87641330007\/\" target=\"_blank\" rel=\"noopener\" title=\"https:\/\/www.usatoday.com\/story\/news\/health\/2025\/12\/06\/blood-pressure-drug-recall-ziac-cross-contamination\/87641330007\/\">USA TODAY<\/a> reported Glenmark Pharmaceuticals recalled more than 11,100 bottles of bisoprolol fumarate and hydrochlorothiazide tablets under the brand name Ziac.<\/p>\n<p class=\"text | article-text\">EN ESPA\u00d1OL | <a href=\"https:\/\/www.telemundobirmingham.com\/2025\/12\/08\/retiran-medicina-para-la-presin-arterial-por-posible-contaminacin-cruzada-segn-reportes\/\" target=\"_self\" rel=\"noopener\" title=\"https:\/\/www.telemundobirmingham.com\/2025\/12\/08\/retiran-medicina-para-la-presin-arterial-por-posible-contaminacin-cruzada-segn-reportes\/\">Retiran medicina para la presi\u00f3n arterial por posible contaminaci\u00f3n cruzada, seg\u00fan reportes<\/a><\/p>\n<p class=\"text | article-text\">Testing of reserve samples found traces of ezetimibe, a cholesterol medicine also made by the company.<\/p>\n<p class=\"text | article-text\">According to <a href=\"https:\/\/thehill.com\/policy\/healthcare\/5636604-high-blood-pressure-medication-voluntarily-recalled-fda\/\" target=\"_blank\" rel=\"noopener\" title=\"https:\/\/thehill.com\/policy\/healthcare\/5636604-high-blood-pressure-medication-voluntarily-recalled-fda\/\">The Hill<\/a>, the Food and Drug Administration said the recalled packages are 30-count bottles, NDC 68462-878-30; 100-count bottles, NDC 68462-878-01; and 500-count bottles, NDC 68462-878-05. The affected lot numbers were set to expire from November 2025 through May 2026.<\/p>\n<p class=\"text | article-text\">The FDA said the medicine is \u201cnot likely to cause adverse health consequences,\u201d but the agency has not said what patients should do if their medication is affected by the recall.<\/p>\n<p class=\"copyright |\">Copyright 2025 Gray Local Media, Inc. All rights reserved.<\/p>\n","protected":false},"excerpt":{"rendered":"(Gray News) &#8211; Blood pressure medicine has been recalled because it may be cross-contaminated with another medication, according&hellip;\n","protected":false},"author":2,"featured_media":620504,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4315],"tags":[193136,193137,174796,173802,193138,90109,105,4326,170482,193139,49557,16,15,193135],"class_list":{"0":"post-620503","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-medication","8":"tag-bisoprolol-fumarate-and-hydrochlorothiazide","9":"tag-bisoprolol-fumarate-and-hydrochlorothiazide-recall","10":"tag-blood-pressure-medicine","11":"tag-blood-pressure-medicine-recall","12":"tag-ezetimibe","13":"tag-glenmark-pharmaceuticals","14":"tag-health","15":"tag-medication","16":"tag-medicine-recall","17":"tag-prescription-recall","18":"tag-recall","19":"tag-uk","20":"tag-united-kingdom","21":"tag-ziac-recall"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@uk\/115685173913786428","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/620503","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/comments?post=620503"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/620503\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media\/620504"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media?parent=620503"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/categories?post=620503"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/tags?post=620503"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}